Questions and answers
Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.
- Written questions must be answered within 10 working days (20 working days during recess)
- Other questions such as Topical, Portfolio, General and First Minister's Question Times are taken in the Chamber
Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.
Filter your results Hide all filters
Displaying 364 questions Show Answers
Question reference: S4W-00684
- Asked by: Margaret McDougall, MSP for West Scotland, Scottish Labour
- Date lodged: Friday, 10 June 2011
- Current Status: Answered by John Swinney on 20 June 2011
To ask the Scottish Executive what (a) discussions, (b) correspondence and (c) meetings it has had with the Scotland Office regarding the location of GlaxoSmithKline's proposed new plant.
Answer
Question reference: S4W-00680
- Asked by: Margaret McDougall, MSP for West Scotland, Scottish Labour
- Date lodged: Friday, 10 June 2011
- Current Status: Answered by John Swinney on 20 June 2011
To ask the Scottish Executive what (a) discussions, (b) correspondence and (c) meetings it has had with GlaxoSmithKline regarding the location of its proposed new plant.
Answer
Question reference: S4W-00681
- Asked by: Margaret McDougall, MSP for West Scotland, Scottish Labour
- Date lodged: Friday, 10 June 2011
- Current Status: Answered by John Swinney on 20 June 2011
To ask the Scottish Executive what (a) discussions, (b) correspondence and (c) meetings it has had with North Ayrshire Council regarding the location of GlaxoSmithKline's proposed new plant.
Answer
Question reference: S4W-00682
- Asked by: Margaret McDougall, MSP for West Scotland, Scottish Labour
- Date lodged: Friday, 10 June 2011
- Current Status: Answered by John Swinney on 20 June 2011
To ask the Scottish Executive what (a) discussions, (b) correspondence and (c) meetings it has had with Angus Council regarding the location of GlaxoSmithKline's proposed new plant.